Investigational ABC transporter inhibitors

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  2012-04-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/13543784.2012.679339PMID 22493979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functions of OATP1A and 1B transporters in vivo: insights from mouse models.

  2012influential reference
• Novel insights into targeting ATP-binding cassette transporters for antitumor therapy.

  2011cited by this paper
• ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux

  2011cited by this paper
• P-glycoprotein inhibition: the past, the present and the future.

  2011cited by this paper
• The ABC transporters of human physiology and disease : genetics and biochemistry of ATP binding cassette transporters

  2011cited by this paper
• The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation

  2011cited by this paper
• Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer.

  2011cited by this paper
• Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

  2011cited by this paper
• Revisiting the ABCs of multidrug resistance in cancer chemotherapy.

  2011cited by this paper
• Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds

  2010cited by this paper
• Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas

  2010cited by this paper
• Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma

  2010cited by this paper
• A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

  2010cited by this paper
• Individual and combined roles of CYP3A, P‐glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel

  2010influential reference
• Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

  2010cited by this paper
• ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.

  2010cited by this paper
• ABC transporters in cancer: more than just drug efflux pumps

  2010cited by this paper
• A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen

  2009cited by this paper
• ABC efflux pump-based resistance to chemotherapy drugs.

  2009cited by this paper
• NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance

  2009cited by this paper
• Is resistance useless? Multidrug resistance and collateral sensitivity.

  2009cited by this paper
• PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.

  2009cited by this paper
• Suppression of ABCG2 inhibits cancer cell proliferation

  2009cited by this paper
• Identification of compounds selectively killing multidrug-resistant cancer cells.

  2009cited by this paper
• Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.

  2009cited by this paper
• A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.

  2009cited by this paper
• A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine

  2009cited by this paper
• Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration

  2008cited by this paper
• Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.

  2008cited by this paper
• Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.

  2008cited by this paper
• Constitutive Expression of the ATP‐Binding Cassette Transporter ABCG2 Enhances the Growth Potential of Early Human Hematopoietic Progenitors

  2008cited by this paper
• Regulation of Prostaglandin Transporters in Colorectal Neoplasia

  2008cited by this paper
• Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 (Cancer Research (2008) 68, (7905-7914))

  2008cited by this paper
• Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.

  2007cited by this paper
• A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX‐710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer

  2007cited by this paper
• Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole

  2007cited by this paper
• Phase III study of PSC‐833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95)

  2006cited by this paper
• Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.

  2006cited by this paper
• ABCA3 as a Possible Cause of Drug Resistance in Childhood Acute Myeloid Leukemia

  2006cited by this paper
• Role of ABCC1 in export of sphingosine-1-phosphate from mast cells

  2006cited by this paper
• Multidrug Resistance and Stem Cells in Acute Myeloid Leukemia

  2006cited by this paper
• Targeting multidrug resistance in cancer

  2006cited by this paper
• Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma

  2005cited by this paper
• Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters.

  2005cited by this paper
• Homozygosity for the 168His variant of the minor histocompatibility antigen HA‐1 is associated with reduced risk of primary Sjögren's syndrome

  2005cited by this paper
• The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing.

  2004influential reference
• Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1

  2004cited by this paper
• Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies

  2004cited by this paper
• Breast Cancer Resistance Protein and P-Glycoprotein in 149 Adult Acute Myeloid Leukemias

  2004cited by this paper
• Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.

  2004cited by this paper
• The ATP switch model for ABC transporters

  2004influential reference
• A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy.

  2004cited by this paper
• A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy

  2004cited by this paper
• ABCA3 gene mutations in newborns with fatal surfactant deficiency.

  2004cited by this paper
• ABC proteins : from bacteria to man

  2003cited by this paper
• Modulation of P‐glycoprotein but not MRP1‐ or BCRP‐mediated drug resistance by LY335979

  2003cited by this paper
• Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.

  2003cited by this paper
• The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs

  2003cited by this paper
• Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.

  2003cited by this paper
• A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies

  2002cited by this paper
• Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.

  2002cited by this paper
• Low levels of ABCG2 expression in adult AML blast samples.

  2002cited by this paper
• A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy.

  2002cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor.

  2001cited by this paper
• Communication between multiple drug binding sites on P-glycoprotein.

  2000cited by this paper
• Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration.

  2000cited by this paper
• Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.

  1999cited by this paper
• Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

  1999cited by this paper
• P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies.

  1999influential reference
• A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis

  1998cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.

  1997cited by this paper
• Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.

  1997cited by this paper
• Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene

  1996cited by this paper
• Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump.

  1996cited by this paper
• Clinical trials of P-glycoprotein reversal in solid tumours.

  1996cited by this paper
• Reconstitution of IKATP: An Inward Rectifier Subunit Plus the Sulfonylurea Receptor

  1995cited by this paper
• The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance.

  1995cited by this paper
• ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.

  1994cited by this paper
• The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates.

  1994cited by this paper
• Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.

  1993cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.

  1991cited by this paper
• Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

  1989cited by this paper
• Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA

  1989cited by this paper
• Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

  1987cited by this paper
• Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

  1986cited by this paper
• Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

  1981cited by this paper
• Simple Allosteric Model for Membrane Pumps

  1966cited by this paper

• Evaluation of natural l‐phenylalanine‐derived Amidohydrazide derivatives in ensuring agriculture production against phytopathogenic fungi†

  2025cites this paper
• Membrane drug transporters in cancer: From chemoresistance mechanism to therapeutic strategies.

  2025cites this paper
• Targeting Drug Resistance in Cancer: Dimethoxycurcumin as a Functional Antioxidant Targeting ABCC3

  2025cites this paper
• Cancer Stem Cell Regulation as a Target of Therapeutic Intervention: Insights into Breast, Cervical and Lung Cancer

  2025cites this paper
• Emerging Strategies to Overcome Chemoresistance: Structural Insights and Therapeutic Targeting of Multidrug Resistance-Linked ATP-Binding Cassette Transporters

  2025cites this paper
• Targeted Cancer Stem Cell Therapeutics: An Update.

  2024cites this paper
• Cancer stem cells in colorectal cancer: signaling pathways involved in stemness and therapy resistance.

  2023cites this paper
• Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy

  2023cites this paper
• Importance of ABC Transporters in the Survival of Parasitic Nematodes and the Prospect for the Development of Novel Control Strategies

  2023cites this paper
• The Molecular Mechanisms of Oleanane Aldehyde-β-enone Cytotoxicity against Doxorubicin-Resistant Cancer Cells

  2023cites this paper
• Structure–Activity Relationships of 8-Hydroxyquinoline-Derived Mannich Bases with Tertiary Amines Targeting Multidrug-Resistant Cancer

  2022cites this paper
• Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells.

  2022cites this paper
• MRP1-targeted Near Infrared Photoimmunotherapy for Drug Resistant Small Cell Lung Cancer.

  2021cites this paper
• The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells

  2021cites this paper
• Effects of kefir on doxorubicin-induced multidrug resistance in human colorectal cancer cells

  2021cites this paper
• Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities.

  2021cites this paper
• Bulbine frutescens phytochemicals as novel ABC-transporter inhibitor: a molecular docking and molecular dynamics simulation study

  2021cites this paper
• Fungal metabolites: A recent trend and its potential biotechnological applications

  2021cites this paper
• Relation of Metal-Binding Property and Selective Toxicity of 8-Hydroxyquinoline Derived Mannich Bases Targeting Multidrug Resistant Cancer Cells

  2021cites this paper
• Myristic Acid Inhibits the Activity of the Bacterial ABC Transporter BmrA

  2021cites this paper
• The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP

  2020cites this paper
• Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).

  2020cites this paper
• Wnt/β-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer

  2020cites this paper
• Functional roles of exosomal miRNAs in multi-drug resistance in cancer chemotherapeutics.

  2020cites this paper
• Aberrant DNA Methylation of ABC Transporters in Cancer

  2020cites this paper
• Ecdysteroid Derivatives that Reverse P-Glycoprotein-Mediated Drug Resistance

  2020cites this paper
• Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy

  2020cites this paper
• Low-intensity low-frequency ultrasound enhances the chemosensitivity of gemcitabine-resistant ASPC-1 cells via PI3K/AKT/NF-κB pathway-mediated ABC transporters

  2020cites this paper
• P-Glycoprotein Efflux Transporters and Its Resistance Its Inhibitors and Therapeutic Aspects

  2020cites this paper
• Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters.

  2020cites this paper
• Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer.

  2020cites this paper
• pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy.

  2020cites this paper
• Unsymmetric dihydropyridines bearing 2-pyridyl methyl carboxylate as modulators of P-glycoprotein; synthesis and biological evaluation in resistant and non-resistant cancer cells

  2019cites this paper
• ABC transporters as cancer drivers: Potential functions in cancer development.

  2019cites this paper
• 10-Phenyltriazoyl Artemisinin is a Novel P-glycoprotein Inhibitor that Suppresses the Overexpression and Function of P-glycoprotein.

  2019cites this paper
• Gaseous signaling molecules and their application in resistant cancer treatment: from invisible to visible.

  2019cites this paper
• ABCC3 is a novel target for the treatment of pancreatic cancer.

  2019cites this paper
• Natural products as multidrug resistance modulators in cancer.

  2019cites this paper
• Mini-review: Current challenges in the treatment of developmentally diverse neuroendocrine like tumors: Comparison of bronchial carcinoids and neuroblastoma

  2019cites this paper
• Proton-irradiated breast cells: molecular points of view

  2019cites this paper
• Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells

  2019cites this paper
• Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins

  2019cites this paper
• Inhibition of Casein Kinase II by CX-4945, But Not Yes-associated protein (YAP) by Verteporfin, Enhances the Antitumor Efficacy of Temozolomide in Glioblastoma

  2019cites this paper
• Imatinib enhances the anti-tumour effect of doxorubicin in canine B-cell lymphoma cell line.

  2019cites this paper
• Oligomeric proanthocyanidins (OPCs) from grape seed extract suppress the activity of ABC transporters in overcoming chemoresistance in colorectal cancer cells.

  2018cites this paper
• MG‑132 reverses multidrug resistance by activating the JNK signaling pathway in FaDu/T cells.

  2018cites this paper
• Side Population: Its Use in the Study of Cellular Heterogeneity and as a Potential Enrichment Tool for Rare Cell Populations

  2018cites this paper
• Stem Cells: Biology and Engineering

  2018cites this paper
• The Effects of Synthetically Modified Natural Compounds on ABC Transporters

  2018influential citation
• ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?

  2018cites this paper
• The role of drug efflux systems in anthelmintic resistance in parasitic nematodes

  2017influential citation
• Obstacles to Brain Tumor Therapy: Key ABC Transporters

  2017cites this paper
• ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance

  2017cites this paper
• Genetics in breast cancer and treatment strategy : A current scenario

  2017cites this paper
• Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells

  2017cites this paper
• Downregulation of ABC Transporters in Non-neoplastic Tissues Confers Better Prognosis for Pancreatic and Colorectal Cancer Patients

  2017cites this paper
• ABC Transporters Involved in Cholestasis

  2017cites this paper
• Cancer Stem Cells in Head and Neck Carcinomas: Identification and Possible Therapeutic Implications.

  2017cites this paper
• Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies

  2017cites this paper
• Probing insecticide biology using Drosophila melanogaster

  2017cites this paper
• Antibiotic That Inhibits the ATPase Activity of an ATP-Binding Cassette Transporter by Binding to a Remote Extracellular Site.

  2017cites this paper
• Shikonin enhances Adriamycin antitumor effects by inhibiting efflux pumps in A549 cells.

  2017cites this paper
• Acides aminés et cancer : LAT1, un transporteur essentiel à l’activité mTORC1 et la croissance tumorale

  2016cites this paper
• Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer.

  2016cites this paper
• Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors.

  2016cites this paper
• Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells

  2016cites this paper
• Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance.

  2016cites this paper
• Synergism between ivermectin and the tyrosine kinase/P-glycoprotein inhibitor crizotinib against Haemonchus contortus larvae in vitro.

  2016influential citation
• Discovering New Antiepileptic Drugs Addressing the Transporter Hypothesis of Refractory Epilepsy: Structure-Based Approximations

  2016cites this paper
• Cancer Stem Cells : Impact on Treatment Therapeutic strategies for targeting cancer stem cells

  2016cites this paper
• Enrichment of Colorectal Cancer Stem Cells by Spheroidal Culture and Gene Expression Analysis of Selected ABC Transporters

  2016cites this paper
• Topología molecular aplicada al reconocimiento de sustratos de la Proteína de Resistencia del Cáncer de Mama (BCRP)

  2016influential citation
• Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2.

  2016cites this paper
• Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors.

  2016cites this paper
• Methylferulate from Tamarix aucheriana inhibits growth and enhances chemosensitivity of human colorectal cancer cells: possible mechanism of action

  2016cites this paper
• ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy.

  2015cites this paper
• MRP1 and its role in anticancer drug resistance

  2015cites this paper
• Dual PI3K/mTOR inhibition with BEZ235 augments the therapeutic efficacy of doxorubicin in cancer without influencing cardiac function

  2015cites this paper
• Chapter 14 – Drugs That Modulate Resistance to Antitumor Agents

  2015cites this paper
• Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein

  2015cites this paper
• Synthesis and characterization of the anticancer and metal binding properties of novel pyrimidinylhydrazone derivatives.

  2015cites this paper
• Kinetics of the Absorption, Distribution, Metabolism, and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator-Activated Receptor Gamma in Rats.

  2015cites this paper
• Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux

  2015cites this paper
• Effects of third generation P-glycoprotein inhibitors on the sensitivity of drug-resistant and -susceptible isolates of Haemonchus contortus to anthelmintics in vitro.

  2015cites this paper
• High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy

  2015cites this paper
• In vitro baselining of new pyrrolopyrimidine EGFR-TK inhibitors with Erlotinib.

  2015cites this paper
• 3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells.

  2015cites this paper
• MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog/smoothened.

  2015cites this paper
• Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells

  2015cites this paper
• The inhibition of ABC transporters in cancer multidrug resistance by heterocyclic cyclohexanone analogues of curcumin

  2014cites this paper
• Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors.

  2014cites this paper
• PlasmaMembrane Transporters inModern Liver Pharmacology

  2014cites this paper
• Important Role of CYP2J2 in Protein Kinase Inhibitor Degradation: A Possible Role in Intratumor Drug Disposition and Resistance

  2014cites this paper
• Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma

  2014cites this paper
• A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival

  2014cites this paper
• Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma Cells

  2014cites this paper
• Special Section on Transporters in Toxicity and Disease — Minireview The Role of Canalicular ABC Transporters in Cholestasis

  2014cites this paper
• Delivery of therapeutic peptides and proteins to the CNS.

  2014cites this paper
• A high throughput flow cytometric assay platform targeting transporter inhibition.

  2014cites this paper
• The phenomenon of multi-drug resistance in the treatment of malignant tumors.

  2014cites this paper